Xario, Toshiba's new ultrasound system, has been tested at the Charité University Hospital, Berlin, by Dr Thomas Fischer, radiologist and ultrasound specialist. In a VISIONS interview, we asked Dr Fischer for his observations.
Increased incidence of vascular diseases and improved medical-imaging technologies expand the application base for contrast media. According to a new study from US market-research group Frost & Sullivan, sales of medical-imaging contrast media will see an impressive 58 per cent rise until 2013.
The next-generation of hybrid imaging technology was presented at this years SNM meeting in Washington, D.C: The first human brain images from a prototype PET/MRI system, which is developed by a collaborative team of German and US researchers from the Universities of Tübingen and Tennessee, as well as Siemens Medical Solutions.
Due to echogenicity differences in comparison with the surrounding liver tissue conventional B-mode-imaging sonography permits the unambiguous classification of the frequently occurring typical liver cysts (criteria: round, echo-free, smoothly demarcated, with edge shadows and sound through transmission) and calcifications (highly reflective, acoustic shadows). The detection and characterization…
Toshiba introduces its new 1.5 MR system in Europe VISIONS: After a period of relative silence Toshiba' MRbusiness division is about to introduce a new system. What is the reason for this increased attention? Hans Baartman: In 2003 a new MRI product, the EXCELART Vantage, was introduced in Japan and the USA where it has become very successful. Because the MRI community is very internationally…
Patients of the Slotervaat Hospital in Amsterdam, Netherlands, now benefit from state-of-the-art Toshiba MRI technology: In May, the hospital commissioned a brand new MRI Vantage System and thus now disposes of premium technology the MRI market currently offers. For Toshiba this new installation is an excellent opportunity to present the companys most recent MRI development on the European market.…
The University Medical Center Hamburg Eppendorf (UKE) is currently undergoing a clinical evaluation with the first MRI/PET image software tool for the diagnosis of neurodegenerative diseases that should support clinicians in diagnosing the onset and type of diseases as early as possible.
Since April, there's been a new man at GE Healthcare´s global MRI division; its new Vice President and General Manager is James E Davis. Meike Lerner caught up with him during the International Society for Magnetic Resonance in Medicine Congress, held recently in Berlin
After a new study published by Professor Stuart Crozier has shown that the use of MR in the clinical practice will not be possible when realizing the EU Physical Agents Directive (EMF) 2004/40/EC on the use of MRI, the European Commission is open to proposing a legislative amendment.
The number of unreported cases of child abuse is extremely high. Experts estimate that there are at least twice as much cases as registered yearly. One reason for this disastrous situation is the fact, that physicians are not trained in reading the signs. Prof Dr Markus Uhl, paediatric radiologists from the University Hospital of Freiburg, Germany, explained to EUROPEAN HOSPITAL which specific…
'If you want to find a needle in a haystack, X-ray is a good tool. Now imagine how much easer that would be if the needle could glow.'
Already in 1993, the world market for contrast media was thought to be worth $ 3 billion. In 2001, an astonishing 12.2 million contrast medium-supported CT studies were carried out in Europe alone. Currently, the overall sales of contrast media are estimated to rise to $ 915 million in Europe in 2008.
A next generation MR-guided intra-operative surgical suite has been installed at Barrow Neurological Institute at St. Joseph's Hospital and Medical Centre following collaboration with GE Healthcare and Maquet GmbH & Co. KG.
When the Siemens board of directors announced its decision for the new Siemens CEO on Sunday, the economic world was surprised: Not only that the name Peter Löscher was never mentioned in the previous discussions about a successor of Klaus Kleinfeld, but hardly anybody knew Loescher´s name in any enconomic context.
First came state-of-the-art equipment, then patients. Now, says Peter Bor×uta, patience is also needed, before perhaps the chance to carry out research becomes a reality. Peter Boruta MD PhD is Professor of Radiology and Head of Radiology at Slovak Medical University, in Bratislava, and Director of the Diagnostic Imaging Institute in Trnava.
Children are not small adults. As well as special technical requirements, their treatment needs particular handling by the radiology team.
Gadofosveset trisodium (trade name: Vasovist) is the first approved blood pool contrast agent worldwide for the diagnosis of vascular disease, Bayer Schering Pharma AG reports.
A new, powerful alliance, comprised of leading politicians and healthcare groups (see box), aims to pressure EU Authorities to revise the controversial directive 2004/40/EC (EMF)*.
Austria - In recent years scientists have produced multi-channel MRI systems, new coil concepts and new contrast media, all of which have helped to shift radiology towards the centre of patient care.
This was the motto of the ECR 2007 in Vienna, where a group of high-ranking experts discussed diseases of the 21st century; research competition between the US and Europe; the conditions needed to progress leading medical R&D - moderated by Congress President Professor Christian J Herold.
Dr A Tamosiunas, Associate Professor at the Radiology Centre in the Medical Faculty at Vilnius University, Lithuania, and Director of the Radiology Centre at Vilnius University Hospital, discusses the present situation and future development of the radiology services in Lithuania with EH correspondent Andrius Vagoras
GE Healthcare and Barrow Neurological Institute at St. Joseph's Hospital and Medical Center implementet a MR-guided intra-operative surgical suite. This new system includes one of the world's most comprehensive portfolio of neuro-imaging solutions, which uses three-dimensional imaging to navigate and validate treatments to help increase both the accuracy and speed of interventions while improving…
Bracco Imaging announces that the MR Angiography indication for MultiHance has been approved by the EU member states via a mutual recognition procedure. MultiHance is a gadolinium based contrast agent that is characterized by high relaxivity and dual route of excretion.
One of Europe's most modern radiology and diagnostics centres opened in Vienna-Donaustadt, Austria, this January.